HomeCompareDOCRF vs CL

DOCRF vs CL: Dividend Comparison 2026

DOCRF yields 9756.10% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DOCRF wins by $43230381229833840.00M in total portfolio value
10 years
DOCRF
DOCRF
● Live price
9756.10%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43230381229833840.00M
Annual income
$42,375,942,331,967,610,000,000.00
Full DOCRF calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — DOCRF vs CL

📍 DOCRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDOCRFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DOCRF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DOCRF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DOCRF
Annual income on $10K today (after 15% tax)
$829,268.29/yr
After 10yr DRIP, annual income (after tax)
$36,019,550,982,172,465,000,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, DOCRF beats the other by $36,019,550,982,172,465,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DOCRF + CL for your $10,000?

DOCRF: 50%CL: 50%
100% CL50/50100% DOCRF
Portfolio after 10yr
$21615190614916920.00M
Annual income
$21,187,971,165,983,804,000,000.00/yr
Blended yield
98.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

DOCRF
No analyst data
Altman Z
-7.4
Piotroski
3/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DOCRF buys
0
CL buys
0
No recent congressional trades found for DOCRF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDOCRFCL
Forward yield9756.10%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$43230381229833840.00M$40.8K
Annual income after 10y$42,375,942,331,967,610,000,000.00$5,401.96
Total dividends collected$43173501257510792.00M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: DOCRF vs CL ($10,000, DRIP)

YearDOCRF PortfolioDOCRF Income/yrCL PortfolioCL Income/yrGap
1← crossover$986,310$975,609.76$11,012$312.01+$975.3KDOCRF
2$90,985,578$89,930,226.22$12,196$412.95+$90.97MDOCRF
3$7,850,557,226$7,753,202,657.96$13,599$549.66+$7850.54MDOCRF
4$633,609,188,528$625,209,092,296.54$15,288$736.64+$633609.17MDOCRF
5$47,836,734,147,594$47,158,772,315,868.44$17,353$995.28+$47836734.13MDOCRF
6$3,378,690,702,500,742$3,327,505,396,962,816.50$19,926$1,357.80+$3378690702.48MDOCRF
7$223,260,494,299,726,370$219,645,295,248,050,560.00$23,194$1,873.82+$223260494299.70MDOCRF
8$13,803,319,479,942,732,000$13,564,430,751,042,025,000.00$27,439$2,621.52+$13803319479942.71MDOCRF
9$798,541,026,043,208,800,000$783,771,474,199,670,000,000.00$33,088$3,727.38+$798541026043208.75MDOCRF
10$43,230,381,229,833,840,000,000$42,375,942,331,967,610,000,000.00$40,806$5,401.96+$43230381229833840.00MDOCRF

DOCRF vs CL: Complete Analysis 2026

DOCRFStock

CloudMD Software & Services Inc. operates as a healthcare technology company in North America. The company operates through three segments: Clinic Services & Pharmacies, Digital Health Services, and Enterprise Health Solutions. It offers enterprise health solutions, including mental health support, healthcare navigation, rehabilitation and assessments, education, and absence management and occupational health. The company also provides billing and electronic medical records solutions; MyHealthAccess, a patient portal that enables online appointment booking and virtual care visits; and Health and Wellness, a real time intervention and prevention platform, which enables an automated real time inquiry of disparate data sources in various domains, identify indicators, and compute risk scores. In addition, it offers iMD platform for peer-reviewed educational resources; telemedicine services; and VisionPros, an online vision care platform that provides contact lenses to customers. Further, the company operates a network of hybrid medical and rehabilitation clinics; and medical clinics for family practice and patient care on-site, as well as retails prescription drugs, over-the-counter drugs, and other front store items through two pharmacies. Additionally, it provides patient support programs that offers navigation and support for holistic disease management and clinical treatment outcomes; and pharmaceutical logistic services, including drug distribution and patient navigation assistance, as well as real-time universal disease management software. The company was formerly known as Premier Health Group Inc. and changed its name to CloudMD Software & Services Inc. in February 2020. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.

Full DOCRF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this DOCRF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DOCRF vs SCHDDOCRF vs JEPIDOCRF vs ODOCRF vs KODOCRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.